Overexpression of sphingosine kinase 1 in liver reduces triglyceride content in mice fed a low but not high-fat diet

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1851, Issue 2, 2015, Pages 210-219

  Kowalski, Greg M ^a,b   Kloehn, Joachim ^c   Burch, Micah L ^b   Selathurai, Ahrathy ^a   Hamley, Steven ^a   Bayol, Stéphanie A M ^a   Lamon, Séverine ^a   Watt, Matthew J ^b   Lee Young, Robert S ^d   McConville, Malcolm J ^c   Bruce, Clinton R ^a,b  

^a DEAKIN UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Ceramide; Diacylglycerol; Glucose tolerance; Liver; Sphingosine kinase 1; Triacylglycerol

Indexed keywords

CERAMIDE; DIACYLGLYCEROL; GLUCOSE; SPHINGOSINE KINASE 1; TRIACYLGLYCEROL; FAT INTAKE; MESSENGER RNA; PHOSPHOTRANSFERASE; SPHINGOSINE KINASE; SUGAR INTAKE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; GLUCONEOGENESIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; GLYCOGENOLYSIS; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIVER; LOW FAT DIET; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; COMPARATIVE STUDY; ENZYMOLOGY; FAT INTAKE; GENETICS; HOMEOSTASIS; METABOLISM; SUGAR INTAKE; TIME; UPREGULATION;

MUS;

ANIMALS; CERAMIDES; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; DIETARY FATS; DIETARY SUCROSE; GLUCOSE; HOMEOSTASIS; LIVER; MALE; MICE, INBRED C57BL; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RNA, MESSENGER; TIME FACTORS; TRIGLYCERIDES; UP-REGULATION;

EID: 84918566087     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2014.12.002     Document Type: Article

References (80)

1. G.M. Reaven Insulin resistance, the insulin resistance syndrome, and cardiovascular disease Panminerva Med. 47 4 2005 201 210
2. R.A. DeFronzo Pathogenesis of type 2 diabetes mellitus Med. Clin. North Am. 88 4 2004 787 835 ix
3. V.T. Samuel Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease J. Biol. Chem. 279 31 2004 32345 32353
4. C. Brons Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men J. Physiol. (Lond.) 587 10 2009 2387 2397
5. J.N. Clore, S.T. Helm, and W.G. Blackard Loss of hepatic autoregulation after carbohydrate overfeeding in normal man J. Clin. Investig. 96 4 1995 1967 1972
6. M.A. Cornier, B.C. Bergman, and D.H. Bessesen The effects of short-term overfeeding on insulin action in lean and reduced-obese individuals Metab. Clin. Exp. 55 9 2006 1207 1214
7. S.P. Kim Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog Diabetes 52 10 2003 2453 2460
8. E.W. Kraegen Development of muscle insulin resistance after liver insulin resistance in high-fat fed rats Diabetes 40 11 1991 1397 1403
9. N. Turner Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding Diabetologia 56 7 2013 1638 1648
10. E.L. Lim Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol Diabetologia 54 10 2011 2506 2514
11. A. Seppala-Lindroos Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men J. Clin. Endocrinol. Metab. 87 7 2002 3023 3028
12. K.F. Petersen Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes Diabetes 54 3 2005 603 608
13. V.T. Samuel, K.F. Petersen, and G.I. Shulman Lipid-induced insulin resistance: unravelling the mechanism Lancet 375 9733 2010 2267 2277
14. G. Marchesini Association of nonalcoholic fatty liver disease with insulin resistance Am. J. Med. 107 5 1999 450 455
15. F. Magkos Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects Gastroenterology 142 7 2012 1444 1446 (e2)
16. J.A. Chavez, and S.A. Summers A ceramide-centric view of insulin resistance Cell Metab. 15 5 2012 585 594
17. P. Angulo Nonalcoholic fatty liver disease N. Engl. J. Med. 346 16 2002 1221 1231
18. B.T. Bikman, and S.A. Summers Sphingolipids and hepatic steatosis Adv. Exp. Med. Biol. 721 2011 87 97
19. M. Bektas Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liver J. Biol. Chem. 285 14 2010 10880 10889
20. Y.A. Hannun, and L.M. Obeid Principles of bioactive lipid signalling: lessons from sphingolipids Nat. Rev. Mol. Cell Biol. 9 2 2008 139 150
21. M. Maceyka SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism J. Biol. Chem. 280 44 2005 37118 37129
22. L.C. Edsall Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells J. Neurochem. 76 5 2001 1573 1584
23. C.R. Bruce Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high fat-fed mice Diabetes 61 12 2012 3148 3155
24. K. Kitajima Complete prevention of atherosclerosis in apoE-deficient mice by hepatic human apoE gene transfer with adeno-associated virus serotypes 7 and 8 Arterioscler. Thromb. Vasc. Biol. 26 8 2006 1852 1857
25. A.C. Nathwani Adenovirus-associated virus vector-mediated gene transfer in hemophilia B N. Engl. J. Med. 365 25 2011 2357 2365
26. A. Caumo, and C. Cobelli Hepatic glucose production during the labeled IVGTT: estimation by deconvolution with a new minimal model Am. J. Physiol. 264 5 Pt 1 1993 E829 E841
27. C. Cobelli The oral minimal model method Diabetes 63 4 2014 1203 1213
28. C. Cobelli Advancing our understanding of the glucose system via modeling: a perspective IEEE Trans. Biomed. Eng. 61 5 2014 1577 1592
29. 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects J. Clin. Invest. 97 1 1996 126 132
30. B. Vaitheesvaran Advantages of dynamic "closed loop" stable isotope flux phenotyping over static "open loop" clamps in detecting silent genetic and dietary phenotypes Metabolomics 6 2 2010 180 190
31. J. Xu Decreased hepatic futile cycling compensates for increased glucose disposal in the Pten heterodeficient mouse Diabetes 55 12 2006 3372 3380
32. 13C]glucose PLoS ONE 7 3 2012 e34042
33. E.S. Jin Increased hepatic fructose 2,6-bisphosphate after an oral glucose load does not affect gluconeogenesis J. Biol. Chem. 278 31 2003 28427 28433
34. S. Karlander Glucose and fructose 6-phosphate cycle in humans Am. J. Physiol. 251 5 Pt 1 1986 E530 E536
35. S. Efendic, A. Wajngot, and M. Vranic Increased activity of the glucose cycle in the liver: early characteristic of type 2 diabetes Proc. Natl. Acad. Sci. U. S. A. 82 9 1985 2965 2969
36. M. Vranic, A. Wajngot, and S. Efendic New probes to study insulin resistance in men; futile cycle and glucose turnover Adv. Exp. Med. Biol. 189 1985 227 245
37. S. Efendic, S. Karlander, and M. Vranic Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity J. Clin. Invest. 81 6 1988 1953 1961
38. M.K. Hellerstein, and R.A. Neese Mass isotopomer distribution analysis at eight years: theoretical, analytic, and experimental considerations Am. J. Physiol. 276 6 Pt 1 1999 E1146 E1170
39. B.R. Landau Contributions of gluconeogenesis to glucose production in the fasted state J. Clin. Invest. 98 2 1996 378 385
40. F.Q. Nuttall, A. Ngo, and M.C. Gannon Regulation of hepatic glucose production and the role of gluconeogenesis in humans: is the rate of gluconeogenesis constant? Diabetes Metab. Res. Rev. 24 6 2008 438 458
41. G. Boden, X. Chen, and T.P. Stein Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus Am. J. Physiol. Endocrinol. Metab. 280 1 2001 E23 E30
42. 2O for estimating rates of gluconeogenesis. Application to the fasted state J. Clin. Invest. 95 1 1995 172 178
43. S.F. Previs, and H. Brunengraber Methods for measuring gluconeogenesis in vivo Curr. Opin. Clin. Nutr. Metab. Care 1 5 1998 461 465
44. M.R. Antoniewicz, J.K. Kelleher, and G. Stephanopoulos Measuring deuterium enrichment of glucose hydrogen atoms by gas chromatography/mass spectrometry Anal. Chem. 83 8 2011 3211 3216
45. S.C. Burgess Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver Cell Metab. 5 4 2007 313 320
46. S.C. Burgess Effect of murine strain on metabolic pathways of glucose production after brief or prolonged fasting Am. J. Physiol. Endocrinol. Metab. 289 1 2005 E53 E61
47. M.K. Hellerstein In vivo measurement of fluxes through metabolic pathways: the missing link in functional genomics and pharmaceutical research Annu. Rev. Nutr. 23 2003 379 402
48. V. Shah Headspace analyses of acetone: a rapid method for measuring the 2H-labeling of water Anal. Biochem. 404 2 2010 235 237
49. D. Yang Assay of low deuterium enrichment of water by isotopic exchange with [U-13C3]acetone and gas chromatography-mass spectrometry Anal. Biochem. 258 2 1998 315 321
50. 2O incorporation into the glycerol moiety and application of MIDA Am. J. Physiol. Endocrinol. Metab. 285 4 2003 E790 E803
51. J. Folch, M. Lees, and G.H. Sloane Stanley A simple method for the isolation and purification of total lipides from animal tissues J. Biol. Chem. 226 1 1957 497 509
52. D.A. Vessey, M. Kelley, and J.S. Karliner A rapid radioassay for sphingosine kinase Anal. Biochem. 337 1 2005 136 142
53. J. Preiss Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells J. Biol. Chem. 261 19 1986 8597 8600
54. A. Aguilera-Romero, C. Gehin, and H. Riezman Sphingolipid homeostasis in the web of metabolic routes Biochim. Biophys. Acta 1841 5 2014 647 656
55. T.A. Taha, Y.A. Hannun, and L.M. Obeid Sphingosine kinase: biochemical and cellular regulation and role in disease J. Biochem. Mol. Biol. 39 2 2006 113 131
56. M.J. Watt Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide Diabetologia 55 10 2012 2741 2746
57. J. Boon Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance Diabetes 62 2 2013 401 410
58. S.M. Hammad Blood sphingolipidomics in healthy humans: impact of sample collection methodology J. Lipid Res. 51 10 2010 3074 3087
59. M.N. Barber Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes PLoS ONE 7 7 2012 e41456
60. N. Yahagi A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids J. Biol. Chem. 274 50 1999 35840 35844
61. H. Shimano Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes J. Biol. Chem. 274 50 1999 35832 35839
62. T.S. Worgall Sphingolipid synthetic pathways are major regulators of lipid homeostasis Adv. Exp. Med. Biol. 721 2011 139 148
63. T.S. Worgall Unsaturated fatty acid-mediated decreases in sterol regulatory element-mediated gene transcription are linked to cellular sphingolipid metabolism J. Biol. Chem. 277 6 2002 3878 3885
64. T.S. Worgall Ceramide synthesis correlates with the posttranscriptional regulation of the sterol-regulatory element-binding protein Arterioscler. Thromb. Vasc. Biol. 24 5 2004 943 948
65. J.M. Aerts Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity Diabetes 56 5 2007 1341 1349
66. G. Yang Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome Am. J. Physiol. Endocrinol. Metab. 297 1 2009 E211 E224
67. N. Bijl Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice Hepatology 50 5 2009 1431 1441
68. H. Zhao Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice Hepatology 50 1 2009 85 93
69. M.W. Lee, and D.L. Severson Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action Am. J. Physiol. 267 3 Pt 1 1994 C659 C678
70. Y.A. Hannun, and L.M. Obeid The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind J. Biol. Chem. 277 29 2002 25847 25850
71. N. Takuwa S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species Cardiovasc. Res. 85 3 2010 484 493
72. R.V. Farese Jr. The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance Cell Metab. 15 5 2012 570 573
73. M. Monetti Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver Cell Metab. 6 1 2007 69 78
74. A.E. Mehran Hyperinsulinemia drives diet-induced obesity independently of brain insulin production Cell Metab. 16 6 2012 723 737
75. K.F. Leavens Akt2 is required for hepatic lipid accumulation in models of insulin resistance Cell Metab. 10 5 2009 405 418
76. R.A. Coleman, T.M. Lewin, and D.M. Muoio Physiological and nutritional regulation of enzymes of triacylglycerol synthesis Annu. Rev. Nutr. 20 2000 77 103
77. T.C. Delgado Sources of hepatic triglyceride accumulation during high-fat feeding in the healthy rat NMR Biomed. 22 3 2009 310 317
78. M.H. Oosterveer High fat feeding induces hepatic fatty acid elongation in mice PLoS ONE 4 6 2009 e6066
79. J.A. Duarte A HFD suppresses de novo lipogenesis and desaturation, but not elongation and triglyceride synthesis in mice J Lipid Res 55 12 2014 2541 2553
80. M.M. Ma Sphingosine kinase 1 participates in insulin signalling and regulates glucose metabolism and homeostasis in KK/Ay diabetic mice Diabetologia 50 4 2007 891 900